{"id":"https://openalex.org/W2106413636","doi":"https://doi.org/10.1001/jama.288.2.169","title":"Dual vs Single Protease Inhibitor Therapy Following Antiretroviral Treatment Failure A Randomized Trial","display_name":"Dual vs Single Protease Inhibitor Therapy Following Antiretroviral Treatment Failure A Randomized Trial","alternate_titles":[],"publication_year":2002,"publication_date":"2002-07-10","ids":{"openalex":"https://openalex.org/W2106413636","doi":"https://doi.org/10.1001/jama.288.2.169","mag":"2106413636","pmid":"https://pubmed.ncbi.nlm.nih.gov/12095381"},"language":"en","primary_location":{"id":"doi:10.1001/jama.288.2.169","doi":"https://doi.org/10.1001/jama.288.2.169","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jama.288.2.169","pdf_url":null,"source":{"id":"https://openalex.org/S172573765","display_name":"JAMA","issn_l":"0002-9955","issn":["0002-9955","0098-7484","1538-3598","2376-8118"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2106413636"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111488347","display_name":"Scott M. Hammer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]},{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Scott M. Hammer","raw_affiliation_strings":["Division of Infectious Diseases, Department of Medicien, Columbia University College of Physicians and Surgeons, 630 W 168th St, New York, NY 10032, USA. smh48@columbia.edu","Division of Infectious Diseases, Department of Medicien, Columbia University College of Physicians and Surgeons, 630 W 168th St, New York, NY 10032, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, Department of Medicien, Columbia University College of Physicians and Surgeons, 630 W 168th St, New York, NY 10032, USA. smh48@columbia.edu","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I78577930"]},{"raw_affiliation_string":"Division of Infectious Diseases, Department of Medicien, Columbia University College of Physicians and Surgeons, 630 W 168th St, New York, NY 10032, USA","institution_ids":["https://openalex.org/I78577930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5158825129","display_name":"Vaida, Florin, PhD","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Florin Vaida","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089772409","display_name":"Kara K. Bennett","orcid":"https://orcid.org/0000-0002-9465-8983","observed_orcids":["https://orcid.org/0000-0002-9465-8983"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kara K Bennett","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161988320","display_name":"Mary K Holohan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mary K Holohan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161962062","display_name":"Lewis Sheiner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lewis Sheiner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161898677","display_name":"Joseph J Eron","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph J Eron","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161893184","display_name":"Lawrence Joseph Wheat","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lawrence Joseph Wheat","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087813701","display_name":"Ronald T. Mitsuyasu","orcid":"https://orcid.org/0000-0002-2627-6246","observed_orcids":["https://orcid.org/0000-0002-2627-6246"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ronald T Mitsuyasu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062018854","display_name":"Roy M. Gulick","orcid":"https://orcid.org/0000-0002-1431-8912","observed_orcids":["https://orcid.org/0000-0002-1431-8912"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roy M Gulick","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057833416","display_name":"Fred T. Valentine","orcid":"https://orcid.org/0000-0002-6046-5913","observed_orcids":["https://orcid.org/0000-0002-6046-5913"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fred T Valentine","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088973456","display_name":"Judith A. Aberg","orcid":"https://orcid.org/0000-0001-8162-0284","observed_orcids":["https://orcid.org/0000-0001-8162-0284"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Judith A Aberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161961871","display_name":"Michael D Rogers","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael D Rogers","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161922221","display_name":"Cheryl N Karol","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cheryl N Karol","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161932332","display_name":"Alfred J Saah","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alfred J Saah","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108110360","display_name":"Ronald H. Lewis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ronald H Lewis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006304664","display_name":"Laura Bessen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura J Bessen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161926439","display_name":"Carol Brosgart","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carol Brosgart","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161795245","display_name":"Victor DeGruttola","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Victor DeGruttola","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5161848185","display_name":"John W Mellors","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John W Mellors","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5111488347"],"corresponding_institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I78577930"],"apc_list":null,"apc_paid":null,"fwci":14.1477,"has_fulltext":false,"cited_by_count":183,"citation_normalized_percentile":{"value":0.99267251,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"288","issue":"2","first_page":"169","last_page":"169"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-infection","display_name":"HIV infection","score":0.5170000195503235},{"id":"https://openalex.org/keywords/protease-inhibitors","display_name":"protease inhibitors","score":0.7429999709129333},{"id":"https://openalex.org/keywords/antiretroviral-therapy-failure","display_name":"antiretroviral therapy failure","score":0.8379999995231628},{"id":"https://openalex.org/keywords/virologic-failure","display_name":"virological failure","score":0.8420000076293945},{"id":"https://openalex.org/keywords/saquinavir","display_name":"saquinavir","score":0.8230000138282776},{"id":"https://openalex.org/keywords/indinavir","display_name":"indinavir","score":0.9950000047683716},{"id":"https://openalex.org/keywords/nelfinavir","display_name":"nelfinavir","score":1.0},{"id":"https://openalex.org/keywords/amprenavir","display_name":"amprenavir","score":0.8690000176429749},{"id":"https://openalex.org/keywords/non-nucleoside-reverse-transcriptase-inhibitors","display_name":"non-nucleoside reverse transcriptase inhibitors","score":0.8050000071525574},{"id":"https://openalex.org/keywords/viral-suppression","display_name":"viral suppression","score":0.5460000038146973},{"id":"https://openalex.org/keywords/cd4-count","display_name":"CD4 count","score":0.8809999823570251},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.4830000102519989},{"id":"https://openalex.org/keywords/highly-active-antiretroviral-therapy","display_name":"highly active antiretroviral therapy","score":0.6600000262260437}],"concepts":[{"id":"https://openalex.org/C2777210460","wikidata":"https://www.wikidata.org/wiki/Q425490","display_name":"Indinavir","level":5,"score":0.8799173831939697},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8632384538650513},{"id":"https://openalex.org/C2781160516","wikidata":"https://www.wikidata.org/wiki/Q423366","display_name":"Nelfinavir","level":5,"score":0.8185151815414429},{"id":"https://openalex.org/C2776937687","wikidata":"https://www.wikidata.org/wiki/Q422654","display_name":"Saquinavir","level":5,"score":0.8008593320846558},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.6817532777786255},{"id":"https://openalex.org/C2777363262","wikidata":"https://www.wikidata.org/wiki/Q422198","display_name":"Amprenavir","level":5,"score":0.6483480334281921},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6261121034622192},{"id":"https://openalex.org/C2781432083","wikidata":"https://www.wikidata.org/wiki/Q422645","display_name":"Efavirenz","level":5,"score":0.6249357461929321},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5360892415046692},{"id":"https://openalex.org/C2779298103","wikidata":"https://www.wikidata.org/wiki/Q422618","display_name":"Ritonavir","level":5,"score":0.4943389892578125},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4787937104701996},{"id":"https://openalex.org/C2779889181","wikidata":"https://www.wikidata.org/wiki/Q423984","display_name":"Stavudine","level":5,"score":0.43811625242233276},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4316995143890381},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3434896767139435},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3410167098045349},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.15457093715667725},{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.1461792290210724},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.06009066104888916},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C2777583353","wikidata":"https://www.wikidata.org/wiki/Q410261","display_name":"HIV-1 protease","level":4,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000099227","descriptor_name":"Abacavir","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000480","descriptor_name":"Alkynes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002219","descriptor_name":"Carbamates","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003521","descriptor_name":"Cyclopropanes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005663","descriptor_name":"Furans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010078","descriptor_name":"Oxazines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D010078","descriptor_name":"Oxazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015224","descriptor_name":"Dideoxynucleosides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D015224","descriptor_name":"Dideoxynucleosides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017211","descriptor_name":"Treatment Failure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017320","descriptor_name":"HIV Protease Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017320","descriptor_name":"HIV Protease Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D017320","descriptor_name":"HIV Protease Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018791","descriptor_name":"CD4 Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019258","descriptor_name":"Saquinavir","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D019258","descriptor_name":"Saquinavir","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019469","descriptor_name":"Indinavir","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D019469","descriptor_name":"Indinavir","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019562","descriptor_name":"Viral Load","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019888","descriptor_name":"Nelfinavir","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D019888","descriptor_name":"Nelfinavir","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D024882","descriptor_name":"Drug Resistance, Viral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048588","descriptor_name":"Benzoxazines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D063065","descriptor_name":"Organophosphonates","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1001/jama.288.2.169","doi":"https://doi.org/10.1001/jama.288.2.169","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jama.288.2.169","pdf_url":null,"source":{"id":"https://openalex.org/S172573765","display_name":"JAMA","issn_l":"0002-9955","issn":["0002-9955","0098-7484","1538-3598","2376-8118"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"journal-article"},{"id":"pmid:12095381","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12095381","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G1355458580","display_name":"COLUMBIA-ADARC-CORNELL AIDS CLINICAL TRIALS UNIT","funder_award_id":"U01AI046386","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G2212129905","display_name":"Center for AIDS Research","funder_award_id":"P30AI027742","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G2736585470","display_name":"General Clinical Research Center","funder_award_id":"M01RR000083","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G284780802","display_name":"SOUTHERN AFRICA-NEW YORK HIV VACCINE TRIALS UNIT","funder_award_id":"U01AI048013","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G3740858242","display_name":"STATISTICAL AND DATA MANAGEMENT CENTER","funder_award_id":"U01AI038855","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G4176192199","display_name":"AIDS CLINICAL TRIALS UNIT","funder_award_id":"U01AI027660","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G4677846744","display_name":"General Clinical Research Center","funder_award_id":"M01RR000865","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G5064896708","display_name":null,"funder_award_id":"RR 00083","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G5730371971","display_name":"COLUMBIA/ROCKEFELLER CENTER FOR AIDS RESEARCH","funder_award_id":"P30AI042848","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G7776077254","display_name":"ADULT AIDS CLINICAL TRIALS UNIT","funder_award_id":"U01AI027665","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"},{"id":"https://openalex.org/F4320337375","display_name":"National Center for Research Resources","ror":"https://ror.org/04pw6fb54"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W28488281","https://openalex.org/W1501551071","https://openalex.org/W1582887581","https://openalex.org/W1789897256","https://openalex.org/W1967957254","https://openalex.org/W1976975094","https://openalex.org/W1980574993","https://openalex.org/W1991485152","https://openalex.org/W1992332433","https://openalex.org/W1997844736","https://openalex.org/W2000906558","https://openalex.org/W2003199949","https://openalex.org/W2004785370","https://openalex.org/W2006069153","https://openalex.org/W2020188944","https://openalex.org/W2025152688","https://openalex.org/W2050508755","https://openalex.org/W2052968172","https://openalex.org/W2057405501","https://openalex.org/W2058299739","https://openalex.org/W2060644115","https://openalex.org/W2073157159","https://openalex.org/W2078301083","https://openalex.org/W2081134354","https://openalex.org/W2083972068","https://openalex.org/W2103232388","https://openalex.org/W2109604183","https://openalex.org/W2111743672","https://openalex.org/W2112857740","https://openalex.org/W2114549408","https://openalex.org/W2120752160","https://openalex.org/W2130154289","https://openalex.org/W2133448156","https://openalex.org/W2133673951","https://openalex.org/W2148291080","https://openalex.org/W2149335010","https://openalex.org/W2150357065","https://openalex.org/W2153990626","https://openalex.org/W2163782297","https://openalex.org/W2164099498","https://openalex.org/W2314511049","https://openalex.org/W2318289184","https://openalex.org/W2321852728","https://openalex.org/W2323801285","https://openalex.org/W2324813721","https://openalex.org/W2329393410","https://openalex.org/W2331670444","https://openalex.org/W2339219218","https://openalex.org/W3026032990"],"related_works":["https://openalex.org/W4232638143","https://openalex.org/W2326728996","https://openalex.org/W2413417512","https://openalex.org/W1987212393","https://openalex.org/W2124756266","https://openalex.org/W2115554276","https://openalex.org/W2335346509","https://openalex.org/W2096522484","https://openalex.org/W1965733923","https://openalex.org/W2105361514"],"abstract_inverted_index":{"CONTEXT:":[0],"Management":[1],"of":[2,28,90,103,205,259,304,336,352,369,380],"antiretroviral":[3],"treatment":[4],"failure":[5,36],"in":[6,32,83,141,172,214,235,243,294,330,367],"patients":[7,33,206,265,276,354,370],"receiving":[8],"protease":[9],"inhibitor":[10,263],"(PI)-containing":[11],"regimens":[12,372],"is":[13],"a":[14,22,29,39,64,101,194,208,256,267,395],"therapeutic":[15],"challenge.":[16],"OBJECTIVE:":[17],"To":[18],"assess":[19],"whether":[20],"adding":[21],"second":[23,51],"PI":[24,118],"improves":[25],"antiviral":[26],"efficacy":[27,154],"4-drug":[30],"combination":[31,142],"with":[34,68,97,143,159,207,274,297,302,333,355,371,394],"virologic":[35],"while":[37],"taking":[38],"PI-containing":[40],"regimen.":[41],"DESIGN:":[42],"Multicenter,":[43],"randomized,":[44],"4-arm":[45],"trial,":[46],"double-blind":[47],"and":[48,57,106,147,175,183,219,229,325,387],"placebo-controlled":[49],"for":[50,60],"PI,":[52],"conducted":[53],"between":[54],"October":[55],"1998":[56],"April":[58],"2000,":[59],"which":[61],"there":[62],"was":[63,240,300,365],"24-week":[65],"primary":[66],"analysis":[67,155],"extension":[69],"to":[70,100,120,287,310,361,385,390],"48":[71],"weeks.":[72,167],"SETTING:":[73],"Thirty-one":[74],"participating":[75],"AIDS":[76],"(acquired":[77],"immunodeficiency":[78,93],"syndrome)":[79],"Clinical":[80],"Trials":[81],"Units":[82],"the":[84,157,215,236,244],"United":[85],"States.":[86],"PARTICIPANTS:":[87],"A":[88],"total":[89],"481":[91,189],"human":[92],"virus":[94],"(HIV)-infected":[95],"persons":[96],"prior":[98,117],"exposure":[99],"maximum":[102],"3":[104],"PIs":[105],"viral":[107,160,173,195,209,268,305,358],"load":[108,161,174,196,210,269,306,359],"above":[109],"1000":[110],"copies/mL.":[111],"INTERVENTION:":[112],"Selectively":[113],"randomized":[114],"assignment":[115],"(per":[116],"exposure)":[119],"saquinavir":[121],"(n":[122,126,130,138],"=":[123,127,131,139,291],"116);":[124],"indinavir":[125],"69);":[128],"nelfinavir":[129],"139);":[132],"or":[133,290,375],"placebo":[134,220],"twice":[135],"per":[136],"day":[137],"157);":[140],"amprenavir,":[144],"abacavir,":[145],"efavirenz,":[146],"adefovir":[148],"dipivoxil.":[149],"MAIN":[150],"OUTCOME":[151],"MEASURES:":[152],"Primary":[153],"involved":[156],"proportion":[158,234,258],"below":[162,197,211,270,311,362],"200":[163,198,212,271,312,363],"copies/mL":[164,199,213,272,313,364],"at":[165,200,307,338],"24":[166,308,339],"Other":[168],"measures":[169],"were":[170,222,392],"changes":[171],"CD4":[176],"cell":[177],"count":[178],"from":[179],"baseline,":[180],"adverse":[181],"events,":[182],"HIV":[184],"drug":[185],"susceptibility.":[186],"RESULTS:":[187],"Of":[188],"patients,":[190],"148":[191],"(31%)":[192],"had":[193,266],"week":[201],"24.":[202],"The":[203,233],"proportions":[204],"saquinavir,":[216],"indinavir,":[217],"nelfinavir,":[218],"arms":[221,239],"34%":[223,227],"(40/116),":[224],"36%":[225],"(25/69),":[226],"(47/139),":[228],"23%":[230,250],"(36/157),":[231],"respectively.":[232],"combined":[237],"dual-PI":[238],"higher":[241,257],"than":[242,327],"amprenavir-plus-placebo":[245],"arm":[246],"(35%":[247],"[112/324]":[248],"vs":[249,279],"[36/157],":[251],"respectively;":[252,282],"P":[253,323,346],"=.002).":[254],"Overall,":[255],"nonnucleoside":[260],"reverse":[261],"transcriptase":[262],"(NNRTI)-naive":[264],"compared":[273,296],"NNRTI-experienced":[275],"(43%":[277],"[115/270]":[278],"16%":[280],"[33/211],":[281],"P<.001).":[283],"Baseline":[284],"HIV-1":[285],"hypersusceptibility":[286,389],"efavirenz":[288,331,391],"(<":[289],"0.4-fold":[292],"difference":[293],"susceptibility":[295],"reference":[298],"virus)":[299],"associated":[301,393],"suppression":[303,337,360],"weeks":[309,340],"(odds":[314],"ratio":[315],"[OR],":[316],"3.49;":[317],"95%":[318,343],"confidence":[319],"interval":[320],"[CI],":[321],"1.62-7.33;":[322],"=.001),":[324],"more":[326],"10-fold":[328],"reduction":[329],"susceptibility,":[332],"less":[334],"likelihood":[335],"(OR,":[341],"0.28;":[342],"CI,":[344],"0.09-0.87;":[345],"=.03).":[347],"CONCLUSIONS:":[348],"In":[349],"this":[350],"study":[351],"antiretroviral-experienced":[353],"advanced":[356],"immunodeficiency,":[357],"achieved":[366],"31%":[368],"containing":[373],"4":[374],"5":[376],"new":[377],"drugs.":[378],"Use":[379],"2":[381],"PIs,":[382],"being":[383],"naive":[384],"NNRTIs,":[386],"baseline":[388],"favorable":[396],"outcome.":[397]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2106413636","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
